Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Grant/Award of 25,000 GANX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 25,000 | n/a |
| Jun 6, 2026 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 16,875 | n/a |
| Jan 30, 2026 | Sarepta Therapeutics, Inc. (SRPT) | Exercise/Conversion | 10,500 | $144.0K |
| Jun 25, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| May 27, 2025 | CASSAVA SCIENCES INC (SAVA) | Grant/Award | 26,500 | n/a |
| Mar 14, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Exercise/Conversion | 9,746 | $245.4K |
| Mar 12, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 2,383 | n/a |
| Jun 27, 2024 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| May 13, 2024 | CASSAVA SCIENCES INC (SAVA) | Grant/Award | 10,000 | n/a |
| Mar 6, 2024 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 1,846 | n/a |